Cargando…
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer tha...
Autores principales: | de las Heras, Begoña, Saini, Kamal S., Boyle, Frances, Ades, Felipe, de Azambuja, Evandro, Bozovic-Spasojevic, Ivana, Romano, Marco, Capelan, Marta, Prasad, Rajeev, Pattu, Pugazhenthi, Massard, Christophe, Portera, Chia, Saini, Monika Lamba, Singh, Brajendra Prasad, Venkitaraman, Ramachandran, McNally, Richard, Leone, Manuela, Grande, Enrique, Gupta, Sudeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402077/ https://www.ncbi.nlm.nih.gov/pubmed/32749634 http://dx.doi.org/10.1007/s40487-020-00124-2 |
Ejemplares similares
-
Effect of the COVID-19 pandemic on cancer treatment and research
por: Saini, Kamal S, et al.
Publicado: (2020) -
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
por: Saini, Kamal S., et al.
Publicado: (2020) -
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
por: Saini, Kamal S., et al.
Publicado: (2020) -
Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016) -
Threat posed by unproven drugs in medical oncology
por: Pondé, Noam, et al.
Publicado: (2016)